Nathan J Cherrington Selected Research

Xenobiotics

1/2022	Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier.
3/2015	Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis.
2/2015	Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.
9/2014	Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.
3/2013	Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.
9/2012	Altered arsenic disposition in experimental nonalcoholic fatty liver disease.
5/2012	Measuring altered disposition of xenobiotics in experimental models of liver disease.
6/2009	Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.
9/2008	Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment.
7/2002	Tissue distribution and chemical induction of multiple drug resistance genes in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathan J Cherrington Research Topics

Disease

43	Non-alcoholic Fatty Liver Disease 10/2022 - 01/2007
13	Drug-Related Side Effects and Adverse Reactions 01/2022 - 08/2011
10	Liver Diseases (Liver Disease) 01/2022 - 08/2005
9	Cholestasis 02/2015 - 11/2004
7	Disease Progression 01/2022 - 12/2010
5	Breast Neoplasms (Breast Cancer) 11/2018 - 10/2007
4	Fibrosis (Cirrhosis) 01/2022 - 03/2013
4	Fatty Liver 12/2017 - 01/2007
4	Alcoholic Fatty Liver 11/2014 - 12/2008
4	Intrahepatic Cholestasis 07/2009 - 07/2004
3	Obesity 04/2016 - 01/2008
3	Inflammation (Inflammations) 11/2014 - 06/2009
2	COVID-19 01/2022 - 12/2021
2	Hepatitis 01/2022 - 08/2005
2	Neoplasms (Cancer) 01/2022 - 07/2002
2	Muscular Diseases (Myopathy) 01/2020 - 03/2014
2	Necrosis 11/2014 - 09/2008
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 09/2013 - 05/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Insulin Resistance 04/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Hepatitis B 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016

Drug/Important Bio-Agent (IBA)

25	Pharmaceutical PreparationsIBA 01/2022 - 10/2007
18	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2007
15	Messenger RNA (mRNA)IBA 11/2018 - 10/2007
12	EnzymesIBA 11/2018 - 01/2008
10	XenobioticsIBA 01/2022 - 07/2002
9	Bile Acids and Salts (Bile Acids)IBA 01/2017 - 08/2005
6	Methionine (L-Methionine)FDA Link 01/2020 - 01/2007
6	Choline (Choline Chloride)IBA 01/2020 - 01/2007
5	AnionsIBA 10/2022 - 09/2008
5	Transcription Factors (Transcription Factor)IBA 12/2016 - 12/2010
4	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2015 - 10/2007
3	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 01/2006
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
3	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2021
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2017 - 10/2009
3	Peptides (Polypeptides)IBA 03/2014 - 09/2008
3	Protein Isoforms (Isoforms)IBA 03/2013 - 12/2010
3	Lithocholic AcidIBA 07/2009 - 03/2008
3	Multidrug Resistance-Associated ProteinsIBA 09/2008 - 10/2007
3	LipopolysaccharidesIBA 03/2007 - 07/2004
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 09/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 07/2014
2	Cytochrome P-450 CYP2C19IBA 12/2017 - 10/2009
2	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 12/2017 - 10/2009
2	Cytochrome P-450 CYP3AIBA 12/2017 - 10/2009
2	Cytochrome P-450 CYP2C9IBA 12/2017 - 10/2009
2	Lysine (L-Lysine)FDA Link 01/2017 - 02/2014
2	CitrullineIBA 01/2017 - 02/2014
2	Membrane Transport Proteins (Biological Pump)IBA 06/2015 - 09/2014
2	Methotrexate (Mexate)FDA LinkGeneric 11/2014 - 11/2014
2	LipidsIBA 11/2014 - 01/2014
2	dimethylethylsilylimidazoleIBA 04/2014 - 01/2008
2	CytokinesIBA 04/2014 - 03/2007
2	SulfotransferasesIBA 09/2013 - 03/2013
2	NF-E2-Related Factor 2IBA 05/2013 - 12/2010
2	Carrier Proteins (Binding Protein)IBA 12/2011 - 09/2008
2	AntioxidantsIBA 12/2010 - 01/2007
2	NAD (NADH)IBA 12/2010 - 01/2006
2	quinone (benzoquinone)IBA 12/2010 - 01/2006
2	DNA (Deoxyribonucleic Acid)IBA 06/2009 - 10/2007
2	Interleukin-1beta (Interleukin 1 beta)IBA 06/2009 - 03/2007
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2007 - 07/2002
1	ochratoxin AIBA 10/2022
1	Agrochemicals (Agricultural Chemicals)IBA 01/2022
1	ParaquatIBA 01/2022
1	Male Contraceptive Agents (Male Contraceptives)IBA 01/2022
1	nirmatrelvirIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	remdesivirIBA 12/2021
1	molnupiravirIBA 12/2021
1	4-nitrobenzylthioinosineIBA 12/2021
1	N(4)-hydroxycytidineIBA 12/2021
1	NucleosidesIBA 12/2021
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2020
1	Folate Receptor 2IBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2018
1	Caffeine (No Doz)FDA LinkGeneric 12/2017
1	Midazolam (Versed)FDA LinkGeneric 12/2017
1	Omeprazole (Prilosec)FDA LinkGeneric 12/2017
1	Losartan (Cozaar)FDA LinkGeneric 12/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	Cholic AcidIBA 01/2017
1	AsparagineIBA 01/2017
1	Betaine (C.B.B.)FDA Link 01/2017
1	Amino Acids FDA Link 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	gamma-Aminobutyric Acid (GABA)IBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2016
1	arseniteIBA 07/2016
1	Hormones (Hormone)IBA 04/2016
1	NucleotidesIBA 01/2016
1	adefovirIBA 01/2016
1	Pemetrexed (MTA)FDA Link 01/2016
1	Reverse Transcriptase InhibitorsIBA 01/2016
1	Folic Acid AntagonistsIBA 01/2016

Therapy/Procedure

1	Cardiopulmonary Resuscitation (CPR) 01/2022